neovascular
- Business
Alvotech and Polifarma sign agreement to commercialise AVT06 in Turkiye
The trial will assess the efficacy, safety and immunogenicity of the therapy combination in the targeted patients. Alvotech has signed…
Read More »
The trial will assess the efficacy, safety and immunogenicity of the therapy combination in the targeted patients. Alvotech has signed…
Read More »